These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8170206)

  • 21. Balsalazide and azathioprine or 6-mercaptopurine.
    Green JR
    Gastroenterology; 1999 Dec; 117(6):1513-4. PubMed ID: 10610346
    [No Abstract]   [Full Text] [Related]  

  • 22. [Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    López-Martín C; de la Fuente-Fernández E; Corbatón P; Sánchez MC; Gisbert JP
    Gastroenterol Hepatol; 2011 Jan; 34(1):16-9. PubMed ID: 21168244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinico-pathologic correlation of liver damage in patients treated with 6-mercaptopurine and Adriamycin.
    Minow RA; Stern MH; Casey JH; Rodriguez V; Luna MA
    Cancer; 1976 Oct; 38(4):1524-8. PubMed ID: 1068739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease.
    Hindorf U; Johansson M; Eriksson A; Kvifors E; Almer SH
    Aliment Pharmacol Ther; 2009 Mar; 29(6):654-61. PubMed ID: 19183142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment.
    Schröder T; Schmidt KJ; Olsen V; Möller S; Mackenroth T; Sina C; Lehnert H; Fellermann K; Büning J
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):698-704. PubMed ID: 25923946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reply: To PMID 23891975.
    Abbas AM; Khan N; Bazzano LA
    Gastroenterology; 2014 Apr; 146(4):1131-3. PubMed ID: 24576737
    [No Abstract]   [Full Text] [Related]  

  • 28. 6-mercaptopurine beats a bum rap.
    Sachar DB
    Gastroenterology; 2003 Aug; 125(2):610-2. PubMed ID: 12891565
    [No Abstract]   [Full Text] [Related]  

  • 29. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
    Timmer A; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2007 Jan; (1):CD000478. PubMed ID: 17253451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypersensitivity to azathioprine in myasthenia gravis.
    Watts GF; Corston R
    Postgrad Med J; 1984 May; 60(703):362-3. PubMed ID: 6539914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and histologic features of Azathioprine-induced hepatotoxicity.
    Siramolpiwat S; Sakonlaya D
    Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe hepatotoxicity with high 6-methylmercaptopurine nucleotide concentrations after thiopurine dose escalation due to low 6-thioguanine nucleotides.
    Gardiner SJ; Gearry RB; Burt MJ; Ding SL; Barclay ML
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1238-42. PubMed ID: 18989148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mercaptopurine rescue after azathioprine-induced liver injury in inflammatory bowel disease.
    Bermejo F; López-Sanromán A; Algaba A; Van-Domselaar M; Gisbert JP; García-Garzón S; Garrido E; Piqueras B; De La Poza G; Guerra I
    Aliment Pharmacol Ther; 2010 Jan; 31(1):120-4. PubMed ID: 19709096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 6-mercaptopurine-induced hepatotoxicity during the treatment of ulcerative colitis: a case study.
    Chen J; Brady P; Saloum Y; Lara S
    Gastroenterol Nurs; 2015; 38(1):65-8. PubMed ID: 25636015
    [No Abstract]   [Full Text] [Related]  

  • 36. Have we overestimated the risk of lymphoma associated with thiopurine treatment for ulcerative colitis?
    Kumar AR; Dudnick RS
    Gastroenterology; 2014 Apr; 146(4):1131. PubMed ID: 24576738
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk of non-melanoma skin cancer with thiopurine use in inflammatory bowel disease.
    Subramaniam K; Pavli P
    J Gastroenterol Hepatol; 2012 Feb; 27(2):193-4. PubMed ID: 22260282
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mixed hepatitis induced by azathioprine].
    de la Serna Higuera C; Moreira Vicente VE; Sanz de Villalobos E
    Med Clin (Barc); 1996 Dec; 107(20):795. PubMed ID: 9019609
    [No Abstract]   [Full Text] [Related]  

  • 39. Decrease in factor V activity: a new adverse effect of purine analogs in inflammatory bowel diseases?
    Poupeney S; Dray X; Reignier S; Vahedi K; Alhenc M; Belluci S; Marteau P
    Inflamm Bowel Dis; 2008 Jul; 14(7):1024-5. PubMed ID: 18286642
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatic and pancreatic damage produced by cytotoxic drugs.
    Woolley PV
    Cancer Treat Rev; 1983 Jun; 10(2):117-37. PubMed ID: 6223696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.